Download Databook
Download Sample
Table of Content
NA : +1 804 441 9344
sales@towardshealthcare.com
Schedule a Meeting
June 2025
Principal Consultant
Reviewed By
The global bioinformatics services market size is calculated at US$ 3.24 in 2024, grew to US$ 3.71 billion in 2025, and is projected to reach around US$ 12.55 billion by 2034. The market is expanding at a CAGR of 14.5% between 2025 and 2034.
| Metric | Details |
| Market Size in 2025 | USD 3.71 Billion |
| Projected Market Size in 2034 | USD 12.55 Billion |
| CAGR (2025 - 2034) | 14.5% |
| Leading Region | North America |
| Market Segmentation | By Type, By Application, By Sector, By Region |
| Top Key Players | Agilent Technologies, Inc., BGI Group, Dotmatics, Labvantage - Biomax GmbH, CD Genomics, Illumina, Inc., PerkinElmer Inc., QIAGEN, Thermo Fisher Scientific Inc., Creative Biolabs, DNAnexus, Inc, DNASTAR, Fios Genomics |
Bioinformatics is a field of study in which by using computing, mathematics, and statistics to examine and elucidate biological data, especially genomic and proteomic information. The bioinformatics services market is driven by factors such as accelerating demand for personalized medicine, which strongly depends on genomic data analysis is crucial for the growth of the market, as well as growing consistent advancement in genomic and proteomic domains, generating huge data that needs bioinformatic services for investigation and interpretation of data.
AI plays an evolutionary role in the market as it provides robust analysis of complicated biological data, boosting research activities, and enhancing the precision of data interpretation. AI can control huge amounts of data sets, detect unseen patterns, and create predictive models, to overcome the difficulties in the traditional method to determine the significant insights from biological data. By using several tools like machine learning (ML), natural language processing (NLP), and deep learning (DL), it is easy to determine patterns, anticipate output, and generate personalized healthcare solutions.
Increasing Demand for Personalized Medicine
A vital driver involved in the growth of the bioinformatics services market is the rising demand for personalized medicine. For this, bioinformatics possesses the tools and techniques that have the ability to examine the large volume of biomedical data, comprising genomic, transcriptomic, and proteomic information. This analysis supports to detection disease disease-causing genes, estimates disease risk, and gains knowledge about individual responses to various treatments.
Rising convolutions and diversity of biological data
It is genuine that bioinformatics can handle huge amounts of datasets, but the rising complexities and diversity of biological data generate restraints in standardization, integration, and quality control as well. This may lead to incorrect results by gaining inadequate and uncertain data, which obstructs the power of bioinformatic services.
Significantly active in drug discovery and clinical diagnostics
For future aspects, there are rising opportunities for the bioinformatic services market are boosting developments in drug discovery and clinical diagnostics. In drug discovery, bioinformatics can investigate massive genomic and proteomic datasets to find potential drug targets, like proteins or enzymes involved in disease mechanisms. Although bioinformatics tools, like DiffDock and Schrödinger Suite, are employed in designing novel drugs. Further, in the case of clinical diagnostics, it is used to analyze gene expression and detect genetic markers.
By type, the NGS segment held the largest revenue share in the market in 2024 and is expected to grow fastest in the upcoming years. NGS is one of the high-throughput technologies that provides faster sequencing of massive volumes of DNA or RNA is allied with bioinformatics, resulting in a robust understanding for researchers about genomes, and can identify disease-causing gene alterations, which lead to the development of novel diagnostic and therapeutic methods.
By type, the scientific software testing segment is expected to grow at a significant rate in the forecast period. This segment has a major role in the bioinformatic services market as it reduces inaccurate interpretation of biological data and inappropriate research outputs by improving the accuracy level. Also, it assists in ensuring the reliability of scientific results and the identification of strong susceptibility and weakness in software.
By application, the drug discovery application segment held the largest share of the market in 2024. In drug discovery, bioinformatics tools are utilized to anticipate the binding tendency and efficiency of drug candidates, permitting researchers to enhance their structure and properties prior to comprehensive wet-lab experiments. This segment in the bioinformatic services market also involves the estimation of drug-target interactions by examining protein structures and molecular dynamics simulations.
For instance,
By application, the proteomics segment is expected to grow at the fastest CAGR in the upcoming years as bioinformatics provides the computational tools and approaches to manage data derived from proteomics experiments, such as data processing, detection of protein, and quantification, along with their alterations. Also in functional analysis, like the identification of protein-protein interactions, the prediction of the role of protein in various pathways, are contributing factors in this segment are impacting the growth of the bioinformatics services market.
By sector, the academic segment led the market in 2024. In academics, researchers use different bioinformatics to raise the focus on generating novel algorithms and tools for examining biological data, oftentimes possessing the objective of advancements in basic understanding of biological mechanisms, including genome sequencing, gene expression analysis, and protein structure estimation.
By sector, the animal segment is expected to grow significantly in the projected timeframe. Bioinformatics is playing a major role in the analysis of genomes of livestock species, supporting researchers to detect genes connected with characteristics such as growth rate, meat quality, and milk production. Moreover, assist in the identification of single-nucleotide polymorphisms (SNPs) and other genetic differences, accelerating the selection of animals with in-demand traits for breeding programs.
North America led the market share by 46% in 2024. In North America, leading players in the biotechnology and pharmaceutical industries are depending on bioinformatics for drug discovery, clinical data analysis, and personalized medicine. Also, this region has well-developed infrastructure for biotechnology and life sciences research is accelerating the growth of the bioinformatics services market. The government is also investing in genetic research and the reimbursement of genomic testing, which is encouraging the growth of the market.
The US is leading in precision medicine, which depends strongly on bioinformatics for investigating massive datasets, including genomics and clinical data, to develop personalized medications. Also, in the research and development sector, bioinformatics is applied in many institutions and companies, which results in advancements in domains like drug discovery, gene therapy, and molecular medicine.
For instance,
Bioinformatics is applied in the development of novel drugs, diagnostics, and personalized medicine processes in Canada. This elevates understanding of disease pathways, identification of biomarkers, and advances targeted therapies. Although, encourages genomics, transformative biology, and proteomics, allowing researchers to analyze huge datasets and generate novel discoveries.
Asia Pacific is expected to grow at the fastest CAGR during the projected period. The bioinformatics services market is driven by boosting government initiatives in biotechnology research and development, and association with academic institutions and industry leaders. In Asia Pacific, increasing disease instances are playing a significant role in the demand for bioinformatics in the analysis of patient data and detection of biomarkers.
In February 2025, QIAGEN consolidated its global bioinformatics leadership by opening a new data center in Australia/Asia-Pacific Region. (Source- Businesswire)
In China, the market growth is fueled by applications of big data analytics and high-throughput sequencing, which allows the development of novel bioinformatics tools and services. Moreover, the Chinese government acknowledges the prospects of bioinformatics to stimulate economic development and increase patient outcomes, resulting in major investments in research provisions and concessions for bioinformatic businesses.
In Japan, the Japan Science and Technology Agency (JST) and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) are supplying significant funding for bioinformatic research, invigorating novel creations and growth in the sector. Raised funding is promoting more research projects in genomics and proteomics, which need bioinformatics services in data analysis and interpretation.
For instance,
In Europe, the escalating growth of biological data, particularly from genomic sequencing and else high-throughput technologies, generates the critical need for robust tools and expertise to examine and interpret this information. Bioinformatics allows tools that provide researchers to acquire significant data from huge datasets, which is a critical step in scientific discovery.
For instance,
In Germany, there is a robust culture of scientific research and revolution, especially in the life sciences, which impacts the development of bioinformatics tools and services. Besides this, the rising demand for bioinformatics services among numerous industries like pharmaceuticals, biotechnology, and agriculture is propelling demand for bioinformatics services.
In the UK, Significant growth of the market is impelled by rising acquisition of bioinformatics in industries like food, agriculture, and forensics to raise product quality, supply chain approaches, and many more. Further, bioinformatics is widely applied in personalized medicine, drug discovery, and diagnostics, fueling the growth of the market.
In May 2024, Azenta, Inc. announced the premiere opening of the new Genomics Laboratory in Oxford, UK, developing its global extend of GENEWIZ Multiomics & Synthesis Solutions further in the UK market. (Source- PR Newswire)
By Type
By Application
By Sector
By Region
June 2025
June 2025
June 2025
June 2025